Kintara Therapeutics, Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kintara Therapeutics, Inc - overview
Established
2009
Location
San Diego, CA, US
Primary Industry
Pharmaceuticals
About
Based in California, US, and founded in 2009 by CSO Dennis M. Brown, Ph. D. , Kintara Therapeutics, Inc.
operates as a biopharmaceutical company providing tumor cancer therapies. In August 2022, Lincoln Park Capital invested USD 20 million in Kintara Therapeutics, Inc. Kintara Therapeutics is a public traded company with the ticker name KTRA. Kintara Therapeutics developed anti-cancer compounds and therapies such as VAL- 083 and REM-001 cancer patients.
The company’s VAL-083 is a molecule chemotherapeutic used for DNA through its therapeutic effect and its ability to cross the blood-brain barrier, critical for activity against central nervous system (CNS) tumors. The firm’s REM-001 is used for the treatment of cutaneous oncology indications and cutaneous metastatic breast cancer (CMBC). In addition, Kintara Therapeutics provides research and development for treatment by collaborating with clinical institutions.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.kintara.com
Total Amount Raised
Subscriber access only
Kintara Therapeutics, Inc - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Announced | Kintara Therapeutics, Inc | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.